Page last updated: 2024-08-24

plerixafor and Burkitt Lymphoma

plerixafor has been researched along with Burkitt Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anthony, K; Dalal, J; Flatt, T; Gamis, A; Gonzalez, C; Jones, R; Lewing, K; Ryan, R	1

Other Studies

1 other study(ies) available for plerixafor and Burkitt Lymphoma

Article	Year
Successful mobilization with AMD3100 and filgrastim with engraftment of autologous peripheral blood stem cells in a heavily pretreated pediatric patient with recurrent Burkitt lymphoma. Pediatric hematology and oncology, 2010, Volume: 27, Issue:2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Burkitt Lymphoma; Cyclams; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Recurrence; Treatment Outcome	2010

Article

Year

Successful mobilization with AMD3100 and filgrastim with engraftment of autologous peripheral blood stem cells in a heavily pretreated pediatric patient with recurrent Burkitt lymphoma.

Pediatric hematology and oncology, 2010, Volume: 27, Issue:2

Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Burkitt Lymphoma; Cyclams; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Recurrence; Treatment Outcome

2010